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Key points
 Thyroid hormones are important regulators of growth and maturation before birth, although
the extent to which their actions are mediated by insulin and the development of pancreatic
beta cell mass is unknown.
 Hypothyroidism in fetal sheep induced by removal of the thyroid gland caused asymmetric
organ growth, increased pancreatic beta cell mass and proliferation, and was associated with
increased circulating concentrations of insulin and leptin.
 In isolated fetal sheep islets studied in vitro, thyroid hormones inhibited beta cell proliferation
in a dose-dependent manner, while high concentrations of insulin and leptin stimulated
proliferation.
 The developing pancreatic beta cell is therefore sensitive to thyroid hormone, insulin and leptin
before birth, with possible consequences for pancreatic function in fetal and later life.
 The findings of this study highlight the importance of thyroid hormones during pregnancy for
normal development of the fetal pancreas.
Abstract Development of pancreatic beta cell mass before birth is essential for normal growth
of the fetus and for long-term control of carbohydrate metabolism in postnatal life. Thyroid
hormones are also important regulatorsof fetal growth, and thepresent study tested thehypotheses
that thyroid hormones promote beta cell proliferation in the fetal ovine pancreatic islets, and that
growth retardation in hypothyroid fetal sheep is associated with reductions in pancreatic beta
cell mass and circulating insulin concentration in utero. Organ growth and pancreatic islet cell
proliferation and mass were examined in sheep fetuses following removal of the thyroid gland
in utero. The effects of triiodothyronine (T3), insulin and leptin on beta cell proliferation rates
were determined in isolated fetal ovine pancreatic islets in vitro. Hypothyroidism in the sheep fetus
resulted in an asymmetric pattern of organ growth, pancreatic beta cell hyperplasia, and elevated
plasma insulin and leptin concentrations. In pancreatic islets isolated from intact fetal sheep, beta
cell proliferation in vitrowas reduced by T3 in a dose-dependent manner and increased by insulin
at high concentrations only. Leptin induced a bimodal response whereby beta cell proliferation
was suppressed at the lowest, and increased at the highest, concentrations. Therefore, proliferation
of beta cells isolated from the ovine fetal pancreas is sensitive to physiological concentrations of
T3, insulin and leptin. Alterations in these hormones may be responsible for the increased beta
cell proliferation and mass observed in the hypothyroid sheep fetus and may have consequences
for pancreatic function in later life.
C© 2017 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society DOI: 10.1113/JP273555
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution
and reproduction in any medium, provided the original work is properly cited.
3332 S. E. Harris and others J Physiol 595.11
(Received 29 September 2016; accepted after revision 11 January 2017; first published online 31 January 2017)
Corresponding author S. E. Harris: Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford
OX1 3PT, UK. Email: shelley.harris@dpag.ox.ac.uk
Abbreviations dGA, days of gestation; EdU, 5-ethynyl-2′-deoxyuride; FBS, fetal bovine serum; IGF, insulin-like growth
factor; KRB, Krebs-Ringer Buffer;MAFA,musculoaponeurotic fibrosarcoma oncogene family A; pHis, phospho-histone
H3; T3, triiodothyronine; T4, thyroxine; TR, thyroid hormone receptors; TX, thyroidectomy.
Introduction
Development of the endocrine pancreas and the onset
of insulin secretion before birth are essential for normal
growth of the fetus. Insulin is a potent growth factor
in utero: intrauterine growth-retardation is associated
with low circulating insulin concentration in the human
fetus (Harding & Johnston, 1995) and experimental
insulin deficiency causes growth-retardation in the ovine
fetus (Fowden et al. 1989). Late gestation is a critical
period for beta cell proliferation in the fetal pancreas
and the establishment of beta cell mass at birth.
Importantly, development of the endocrine pancreas is
sensitive to changes in nutrient availability and circulating
hormone levels in utero with long-term consequences for
carbohydrate metabolism and the risk of type 2 diabetes
in adulthood (Fowden & Hill, 2001; Portha et al. 2011;
Gatford & Simmons, 2013).
Thyroid hormones, thyroxine (T4) and triiodo-
thyronine (T3), also play an important role in the
control of growth, metabolism and development of
the fetus, especially over the prepartum period when
T3 concentrations rise in the fetal circulation (Fisher
& Polk, 1989; Forhead & Fowden, 2014). Congenital
hypothyroidism affects approximately 1 in 3000 human
births every year and causes severe mental and physical
retardation if untreated (LaFranchi, 2011). In animal
models, experimental hypothyroidism in utero impairs
fetal growth and maturation of organ systems, including
the cardiovascular, nervous and skeletomuscular systems
(Finkelstein et al. 1991; Lanham et al. 2011; Patel et al.
2011; Chattergoon et al. 2012; Forhead & Fowden, 2014).
The actions of thyroid hormones on growth and
development of fetal tissues may be both direct and
indirect as they can influence other endocrine systems
before birth. Thyroid hormone deficiency in fetal sheep
alters the availability of hormones and growth factors in
the circulation and tissues, such as leptin and insulin-like
growth factors (IGFs; Forhead et al. 2002; O’Connor et al.
2007). Interactions between insulin and thyroid hormones
in the control of fetal growth and development, however,
are poorly understood. Thyroid hormone receptors, TRα1
and TRβ1, are expressed in the embryonic murine
pancreas (Aiello et al. 2014), and T3 promotes beta
cell proliferation in human and rodent cell lines (Verga
Falzacappa et al. 2006; Furuya et al. 2010; Kim et al. 2014)
and in the embryonic murine pancreas in explant culture
(Aiello et al. 2014). Little is known, however, about the
role of thyroid hormones in the development of the end-
ocrine pancreas and secretion of insulin in the fetus during
late gestation, a critical period when beta cell proliferation
is sensitive to changes in the intrauterine environment
(Bouwens & Rooman, 2005; Portha et al. 2011).
The aims of the current study were to examine (a)
the effects of hypothyroidism in utero on pancreatic
alpha and beta cell mass in the ovine fetus and (b)
the endocrine control of beta cell proliferation in vitro
using isolated fetal ovine pancreatic islets. It was hypo-
thesised that thyroid hormones promote fetal pancreatic
beta cell proliferation in vitro, and that thyroid hormone
deficiency in the ovine fetus during late gestation causes
a decrease in circulating insulin concentration secondary
to a reduction in pancreatic beta cell mass. These changes
in pancreatic development and insulin secretion may, in
turn, be responsible for the impaired body growth seen in
the hypothyroid ovine fetus.
Methods
Ethical approval
All surgical and experimental procedures were carried
out in accordance with UK Home Office legislation and
the Animals (Scientific Procedures) Act 1986, after ethical
approval by the Animal Welfare and Ethical Review Body
of the University of Cambridge, UK.
Animals
Nineteen pregnant Welsh Mountain ewes of known
gestational age and carrying twin fetuses (15 female,
23 male) were maintained on 200 g day−1 concentrates
with hay and water ad libitum. Food, but not water, was
withheld from the ewes for 18–24 h before surgery.
Experimental procedures
At 105–110 days of gestation (dGA; term 145 ± 2 days)
and under isoflurane anaesthesia (1.5% isoflurane in
O2/N2O), the twin fetuses of each ewe underwent
either thyroidectomy (TX) or a sham operation in
which the thyroid gland was exposed but not removed
(Hopkins & Thorburn, 1972). At surgery, antibiotics
were administered to the amniotic cavity of each fetus
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(600 mg benzylpenicillin in 2 ml of 0.9% saline:
Crystapen, Schering-Plough, Welwyn Garden City, UK).
The ewes were given antibiotics (30 mg kg−1 I.M. procaine
benzylpenicillin; Depocillin, Intervet UK Ltd, Milton
Keynes, UK) and an analgesic agent (1 mg kg−1 S.C.
carprofen; Rimadyl, Vet UK, Thirsk, UK) immediately
before the start of surgery, and antibiotic administration
was continued daily for 3 days thereafter. The animals
were monitored over the recovery period and normally
resumed feeding within 24 h of surgery.
At either 129 (n = 18) or 143 dGA (n = 20), the
fetuses were delivered by Caesarean section under general
anaesthesia (20 mg kg−1 maternal body weight sodium
pentobarbitone I.V.). Umbilical arterial blood samples
were collected into EDTA-containing tubes. Each fetus
was weighed and a variety of fetal organs, including
the pancreas, were collected after the animal was killed
(200 mg kg−1 sodium pentobarbitone I.V.).
Hormone measurements
Umbilical plasma T3 and T4 concentrations were
determined by radioimmunoassay (MP Biomedicals,
Loughborough, UK); intra-assay CVs were 3 and 5%, and
minimum levels of detection were 0.14 and 7.0 ng ml−1,
respectively. Plasma insulin and cortisol concentrations
were measured using ELISA kits (insulin: Mercodia,
Uppsala, Sweden; cortisol: IBL International, Hamburg,
Germany); intra-assay CVs were both 9%, and minimum
levels of detection were 0.05 and 2.5 ng ml−1, respectively.
Plasma concentrations of leptin, IGF-I and IGF-II were
determined by radioimmunoassay as previously described
(Blache et al. 2000; Forhead et al. 2011). Intra-assay
CVs were 4–5%, and minimum levels of detection were
0.09, 0.08 and 4.0 ng ml−1, respectively. Plasma glucagon
levels were not determined as the blood samples were not
collected in the appropriate preservative.
Pancreas stereology and immunohistochemistry
The fetal pancreas was fixed in 4% paraformaldehyde
(with 0.2% glutaraldehyde in 0.1 M phosphate buffer)
and embedded in paraffin wax. Each pancreas was
exhaustively cut into 5 μm sections and, with a random
start between 1 and 100, every 100th section was
sampled so that at least 10 sections were collected.
Pancreatic alpha and beta cells were immunolabelled
using mouse monoclonal antibodies against glucagon
(1:1000; Sigma, Poole, UK) and insulin (1:1000; Sigma),
respectively. Detection was achieved using the Vectastain
Elite ABC kit (Vector Laboratories, Peterborough, UK),
diaminobenzidene and methyl-green as a counter-stain.
Digital images were created using a NanoZoomer digital
slide scanner (Hamamatsu Photonics, Welwyn Garden
City, UK) and analysed blind to the treatment group.
Total pancreatic and islet (alpha and beta cell) volumes
were determined by Cavalieri’s principle using NewCAST
stereological software [Visiopharm,Hoersholm,Denmark
(Gundersen & Jensen, 1987; Howard & Reed, 2010)]. In
each section, 10% of the total tissue was sampled, which
was sufficient to provide at least 200 measurements of
glucagon or insulin-positive tissue. Absolute and relative
alpha and beta cell masses were calculated using fetal
body and pancreas weights. A subset of 20 fetuses (n = 5
in each treatment group) were analysed for alpha cell
mass.
Pancreatic alpha and beta cell proliferation
Pancreatic alpha and beta cell proliferation rates
were determined by dual immunolabelling with
guinea-pig anti-porcine insulin (1:500; Dako, Carpinteria,
CA, USA), mouse anti-glucagon (1:500; Sigma) and
rabbit anti-phospho-histone H3 antibodies (pHis;
7.5 μl ml−1; Millipore, Temecula, CA, USA), using
immunofluorescence procedures as described previously
(Limesand et al. 2005; Leos et al. 2010). Immuno-
complexes were detected using anti-rabbit IgG conjugated
to Alexa Fluor-488 and anti-guinea-pig or anti-mouse IgG
conjugated to Alexa Fluor-594 (1:500; Jackson Immuno-
Research Laboratories,West Grove, PA,USA). Nuclei were
stained with DAPI (Vector Laboratories). Both insulin
and glucagon antibodies had been validated previously for
use in pancreatic islets from fetal sheep (Limesand et al.
2013). No staining for insulin or glucagon was observed
in pancreatic tissue outside of the islets or in negative
control samples incubated without the primary antibody.
Images were digitally captured from a Leica DM5500
microscope and analysed using ImageJ. The proportion
of mitotic beta cells was determined from a minimum
count of 200 phospho-histone H3 (pHis)/insulin-positive
cells in a minimum count of 3000 insulin-positive cells
on at least four pancreatic sections from each fetus. The
number of pHis-positive alpha cells was too low to reach
the minimum required for stereological analysis (<1%
total pancreatic tissue).
Isolation of fetal ovine pancreatic islets
The experiments on isolated fetal ovine islets were
performed at the School of Animal and Comparative
Biomedical Sciences, University of Arizona, USA.
Five Columbia-Rambouillet ewes carrying twin fetuses
(4 female, 6male)weremaintained in compliancewith the
Institutional Animal Care and Use Committee, University
of Arizona,which approved the study. Eweswere fed alfalfa
pellets and provided water ad libitum. At 137 ± 5 dGA,
the animals were killed with I.V. sodium pentobarbitone
(86 mg kg−1) and phenytoin sodium (11 mg kg−1).
After delivery of the fetus by Caesarean section, the
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pancreas was perfused, via the common bile duct, with
cold collagenase solution containing Krebs-Ringer Buffer
(KRB), 0.425 mg ml−1 collagenase V (Sigma) and 0.2%
DNase1 (Roche, Indianapolis, IN, USA). Pancreatic islets
were isolated as described previously (Limesand et al.
2006; Rozance et al. 2006) and transferred intoRPMI-1640
media (Sigma) containing 10% fetal bovine serum (FBS;
EquaFetal, Atlas Biologicals, Fort Collins, CO, USA),
penicillin-streptomycin (50 and 100 μg; Sigma) and
2.8 mM glucose. In fetal ovine islets studied in vitro,
this concentration of glucose is the inflection point for
glucose utilisation and oxidation (Limesand et al. 2006;
Rozance et al. 2006). The islets were cultured in 10% FBS
tomaintain a basal rate of cell division; this was important
inorder todemonstrate both increased anddecreased rates
of proliferation in response to hormone treatment.
Hormone treatment and proliferation assay
Islets from three fetuseswere used for each hormone study.
At least 50 islets in each Petri dish were incubated with
eitherT3 (Sigma), insulin (Humulin-R, Lilly, Indianapolis,
IN, USA) or leptin (Abcam, Cambridge, UK) at three
doses: 0.1, 1 and 10 ng ml−1. The effects of T4 were not
assessed as T3 is the active form of thyroid hormone.
An additional dish of islets incubated with 10 ng ml−1
IGF-I (Sigma) was used as a positive control as IGF-I
is known to stimulate beta cell proliferation (Hogg
et al. 1993). The islets were subjected to 95% O2/5%
CO2 gas for 5 min in a humidity chamber before
incubation at 37°C. After 24 h, the islets were transferred
into fresh medium supplemented with hormone and
5-ethynyl-2′-deoxyuride (EdU) at a final concentration
of 10 μM. After a total incubation time of 48 h, the
islets were fixed in 4% paraformaldehyde and frozen in
optimum cutting temperature compound (Tissue Tek,
Torrance, CA, USA). Islets were sectioned at −20°C
to a thickness of 10 μm at 100 μm intervals and
labelled for EdU-positive cells using the Click-iT EdU
Alexa Fluor-488 kit (Invitrogen, Grand Island, NY,
USA).
Immunofluorescent staining
Insulin-positive beta cells were identified by immuno-
staining with a guinea-pig anti-porcine insulin anti-
body (Dako). Immunocomplexes were detected by poly-
clonal donkey anti-guinea-pig Alexa Fluor-594 and
DAPI was used as a counter-stain. At least 2500–3000
insulin-positive cells were identified in at least six
sections per treatment group. The numbers of cells
positive for both EdU and insulin were expressed as
a proportion of the total number of insulin-positive
cells.
Statistical methods
Data from the studies in vivo were analysed by three-way
ANOVA with treatment, gestational age and sex of the
fetus as factors (SigmaStat 3.5, Systat Software, San Jose,
CA, USA). The sex of the fetus had no significant effect
on any of the variables measured; therefore, data from
male and female fetuses were combined and analysed
by two-way ANOVA followed by the Tukey post hoc
test. Data from the studies in vitro were assessed by
one-way ANOVA followed by the Dunnett post hoc test.
Relationships between variables were assessed by linear
regression. Significance was accepted at P ˂ 0.05.
Results
Hypothyroidism in utero increases circulating insulin
and leptin concentrations
In TX fetuses, plasma T4 and T3 concentrations decreased
significantly to below, or close to, the limit of assay
detection at both 129 and 143 dGA (P < 0.05; Table 1).
A developmental rise in plasma T3 concentration was
observed between 129 and 143 dGA in the sham, but
not TX, fetuses (P < 0.05; Table 1). Compared to sham
fetuses, the TX fetuses had significantly higher plasma
concentrations of insulin and leptin at both gestational
ages (P < 0.05; Table 1). There was no effect of TX
on plasma cortisol, IGF-I or IGF-II concentrations, but
cortisol levels were significantly higher in both groups of
fetuses studied at 143 dGA compared to those at 129 dGA
(P < 0.05; Table 1).
Hypothyroidism in utero induces asymmetrical
growth patterns in fetal organs
There were no differences in body weight, crown–rump
length or abdominal circumference between sham and
TX fetuses at either gestational age (Table 1). Relative
weights of the heart, lungs, stomach and small intestines
were significantly lower in TX fetuses compared to sham
fetuses at both 129 and 143 dGA (P < 0.05; Table 1). In
TX fetuses, significant increments were observed in the
relative weights of the kidneys (at 143 dGA) and peri-
renal adipose tissue (at both 129 and 143 dGA; P < 0.05;
Table 1). There was no effect of TX on the relative
mass of the pancreas or liver at either gestational age
(Table 1).
Hypothyroidism in utero induces pancreatic beta cell
hyperplasia
The volume percentage of beta cells in total pancreatic
tissue was significantly greater in TX fetuses compared
to sham fetuses at 129 dGA (sham 3.6 ± 0.4% vs. TX
C© 2017 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Table 1. Mean (±SEM) plasma hormone concentrations and body measurements in sham and TX sheep fetuses at 129 and 143 dGA
129 dGA 143 dGA
Sham (n = 9) TX (n = 9) Sham (n = 10) TX (n = 10)
Plasma hormone concentrations
T3 (ng ml−1) 0.28 ± 0.07 ND∗ 0.65 ± 0.13† ND∗
T4 (ng ml−1) 81.1 ± 15.6 ND∗ 83.0 ± 16.7 ND∗
Insulin (ng l−1) 30.1 ± 9.4 129.4 ± 31.3∗ 55.7 ± 12.0 167.9 ± 19.3∗
Cortisol (ng ml−1) 12.6 ± 3.1 9.8 ± 1.5 54.9 ± 12.7† 28.7 ± 3.9†
Leptin (pg ml−1) 520 ± 40 980 ± 40∗ 670 ± 50 1000 ± 10∗
IGF-I (ng ml−1) 18.4 ± 1.9 21.2 ± 2.8 27.0 ± 5.7 25.3 ± 3.1
IGF-II (ng ml−1) 102.8 ± 10.4 118.8 ± 5.5 105.3 ± 6.7 106.3 ± 3.8
Body measurements
Body weight (kg) 2.61 ± 0.20 2.49 ± 0.20 3.58 ± 0.23† 3.13 ± 0.13†
Crown–rump length (cm) 43.6 ± 1.1 42.1 ± 1.0 48.3 ± 1.1† 45.7 ± 0.7†
Abdominal circumference (cm) 30.8 ± 0.9 29.6 ± 1.2 34.9 ± 0.9† 33.5 ± 0.7†
Organ mass (relative to body mass, %)
Heart 0.63 ± 0.03 0.52 ± 0.01∗ 0.61 ± 0.02 0.52 ± 0.02∗
Lungs 2.86 ± 0.18 2.36 ± 0.08∗ 2.55 ± 0.12 2.29 ± 0.15∗
Empty stomach 0.81 ± 0.04 0.72 ± 0.02∗ 0.82 ± 0.02 0.69 ± 0.03∗
Small intestines 2.00 ± 0.19 1.35 ± 0.07∗ 2.34 ± 0.07† 1.36 ± 0.07∗
Kidneys 0.60 ± 0.03 0.68 ± 0.04 0.52 ± 0.03 0.63 ± 0.03∗
Perirenal adipose 0.39 ± 0.03 0.52 ± 0.1∗ 0.31 ± 0.03 0.48 ± 0.04∗
Pancreas 0.09 ± 0.01 0.09 ± 0.01 0.08 ± 0.01 0.09 ± 0.01
Liver 2.85 ± 0.36 2.73 ± 0.17 2.20 ± 0.07 2.94 ± 0.22
†Significantly different from fetuses in the same treatment group at 129 dGA; ∗significantly different from sham fetuses at the same
gestational age; two-way ANOVA, P < 0.05. ND, not detectable (minimum levels of detection: T3 0.14 ng ml−1, T4 7.0 ng ml−1).
6.2 ± 0.5%, P < 0.05), but not at 143 dGA (sham
5.1 ± 0.7% vs. TX 6.4 ± 0.5%). Absolute beta cell
mass tended to be greater in TX fetuses than in sham
controls at 129 dGA (sham 92.3 ± 24.1 mg vs. TX
144.6 ± 23.5 mg) and 143 dGA (sham 143.9 ± 20.9 mg
vs. TX 183.4 ± 26.8 mg, P = 0.08). In sham, but not
TX, fetuses at 143 dGA, there was a significant increase in
absolute beta cell mass compared to the younger fetuses
at 129 dGA (P < 0.05). When adjusted for fetal body
weight, relative beta cell mass was 30–40% greater in
TX compared to sham fetuses at both gestational ages
(P < 0.05, Fig. 1A). When observations from all fetuses
were considered, regardless of treatment and gestational
age, plasma insulin concentrationwaspositively correlated
with relative pancreatic beta cell mass (r = 0.50, n = 36,
P < 0.005, Fig. 1B). The proportion of proliferating beta
cells was 45–55% greater in TX compared to sham fetuses
at both 129 and 143 dGA (P < 0.05, Fig. 1C). There was
no effect of gestational age on beta cell proliferation rate
in either treatment group (Fig. 1C).
The proportion of alpha cells in total pancreatic tissue
was unchanged in TX compared to control fetuses at
129 dGA (sham 1.4 ± 0.2% vs. TX 1.9 ± 0.3%) and
143 dGA (sham 1.6 ± 0.2% vs. TX 1.5 ± 0.1%). When
adjusted for pancreas weight, there was no effect of
thyroidectomy or gestational age on absolute alpha cell
mass at either 129 dGA (sham 37.3 ± 7.0 mg vs. TX
43.3 ± 6.4 mg) or 143 dGA (sham 41.4 ± 6.9 mg vs.
TX 44.2 ± 4.1 mg). When adjusted for fetal body weight,
there was no change in relative alpha cell mass at either
gestational age (129 dGA: sham 12.6± 1.9 mg kg−1 vs. TX
15.1 ± 2.3 mg kg−1; 143 dGA sham 11.7 ± 0.9 mg kg−1
vs. TX 14.5 ± 1.4 mg kg−1).
Thyroid hormone, insulin and leptin alter fetal beta
cell proliferation in vitro
In experiments in vitro, islets cultured in complete media
without the addition of hormones (basal condition) or
with 10 ng ml−1 IGF-I (positive control) showed beta cell
proliferation rates of 5.7± 0.2 and 8.0± 0.4%, respectively
(Figs 2–4).
T3. Increasing concentrations of T3 caused a significant
reduction in the number of EdU/insulin-positive cells in
isolated fetal ovine islets (P< 0.05; Fig. 2). The rate of beta
cell proliferation was decreased significantly by 0.1, 1 and
10 ng ml−1 T3, in a dose-dependent manner (Fig. 2B).
Insulin. Insulin treatment at 0.1 and 1 ng ml−1 did not
affect the number of EdU/insulin-positive cells in fetal
pancreatic islets (Fig. 3). At the higher dose of 10 ng ml−1
insulin, however, beta cell proliferation rate was increased
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significantly compared to the basal condition and lower
doses of insulin (P < 0.05; Fig. 3B), and tended to be
higher than that induced by 10 ng ml−1 IGF-I (P = 0.07;
Fig. 3B).
Leptin. Incubation with leptin induced a bimodal
response in beta cell proliferation (Fig. 4). A significant
decrease in the number of EdU/insulin-positive cells
was observed after incubation with 0.1 and 1 ng ml−1
leptin (P < 0.05; Fig. 4B). However, at the highest
concentration, 10 ng ml−1 leptin stimulated beta cell
proliferation significantly above that seen in the basal
condition (P< 0.05; Fig. 4B) and similar to that stimulated
by IGF-I (Fig. 4B).
Discussion
This study has shown for the first time, and contrary to
the original hypothesis, that thyroid hormone deficiency
in the ovine fetus caused a 30–40% increment in
pancreatic beta cell mass, secondary to beta cell hyper-
plasia, and a concomitant rise in circulating insulin
concentration in utero. In support of these findings
in vivo, physiological concentrations of T3 reduced,
while insulin stimulated, beta cell proliferation rates in
isolated fetal ovine pancreatic islets studied in vitro.
Plasma leptin concentration was increased by fetal hypo-
thyroidism and pancreatic beta cell proliferation showed
a bimodal response to leptin exposure in vitro. Therefore,
in the developing pancreas, beta cell mass is sensitive to
variations in circulating thyroid hormones, insulin and
leptin before birth.
Hypothyroidism is associated with asymmetric intra-
uterine growth retardation in this and previous studies
(Fisher & Polk, 1989; Kilby et al. 1998; Lanham et al.
2011). Although the thyroid-deficient ovine fetus had
shorter limbs and reduced weights of the heart, lungs and
gastrointestinal tract, other tissues such as the kidneys and
perirenal adipose tissue were enlarged by hypothyroidism
in utero. Before birth, insulin promotes growth of the
axial skeleton and tissues such as adipose tissue (Fowden
et al. 1989), so increased circulating concentrations of
insulin seen in the hypothyroid sheep fetusmay contribute
to maintenance of vertebral length and tissue-specific
patterns of organ growth. The extent to which growth
patterns during hypothyroidism relate to changes in
insulin signalling pathways in these fetal organs, however,
remains to be established.
In hypothyroid fetal sheep, beta cell mass was increased
at both gestational ages studied, without any change
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Figure 1. Pancreatic beta cell mass and proliferation in sham and TX fetuses
A and C, mean (±SEM) pancreatic beta cell (A) relative mass and (C) proliferation rate in sham (white bars) and TX
(black bars) sheep fetuses at 129 and 143 dGA. ∗Significantly different from sham fetuses at the same gestational
age, two-way ANOVA, P < 0.05; n = 8–10 fetuses in each group. B, relationship between relative beta cell mass
and plasma insulin concentration in sham and TX sheep fetuses at 129 and 143 dGA; n = 36, r = 0.50, P ˂ 0.005.
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in absolute or relative mass of the pancreas, although
beta cells were only 3–7% of the total pancreas mass.
Thyroid hormone deficiency in utero appears to induce
a beta cell-specific phenotype as absolute and relative
alpha cell mass was unchanged. The mechanisms by
whichhypothyroidism influences development of the end-
ocrine pancreas during late gestation are largely unknown,
and may involve beta cell neogenesis from pancreatic
progenitor cells and/or replicationofpre-existingbeta cells
(Bouwens et al. 1997). In the pancreas of the human and
ovine fetus, primitive islets and insulin production first
appears at around 25% of gestation, and, thereafter, beta
cells proliferate and secrete insulin throughout gestation
(Fowden & Hill, 2001). Suppression of apoptosis may
also contribute to alterations in pancreatic beta cell mass
in utero, although apoptotic cells comprise only 2% of
the total beta cell population in the intact sheep fetus
during late gestation (Limesand et al. 2005). In humans,
there is a wave of apoptosis in pancreatic islets over the
perinatal period in association with a decline in beta cell
proliferation (Kassem et al. 2000). The prepartum surge
in circulating thyroid hormones may therefore have a
role in this critical period of islet remodelling. Previous
studies have shown that thyroid hormone receptors TRα1
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Figure 2. Beta cell proliferation in T3 treated islets
A, immunofluorescent staining to show insulin (red), EdU (green) and DAPI (blue) in fetal ovine pancreatic islets
cultured in 10 ng ml−1 IGF-I (positive control) or 0, 0.1, 1.0 and 10 ng ml−1 T3. Scale bar = 25 µm. B, mean
(±SEM) proliferation rates in beta cells after incubation with increasing doses of T3 compared to 10 ng ml−1 IGF-I.
Values with different letters are significantly different from each other, one-way ANOVA, P < 0.05.
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and TRβ1 are important for normal islet development in
islets taken from postnatal rodents and in a rat pancreatic
beta cell line (Furuya et al. 2010; Aguayo-Mazzucato et al.
2013). In contrast to the current findings, however, T3
has been shown to stimulate proliferation and reduce
apoptosis in pancreatic beta cells in vitro, although these
studies used islets and cell lines derived from postnatal
rather than fetal animals (Verga Falzacappa et al. 2006,
2010; Kim et al. 2014). The difference in thyroid hormone
action between fetal and postnatal beta cells may be due
to the relative expression of thyroid hormone transporters
and receptors, and the activity of post-receptor pathways.
Thyroid hormone receptor isoforms are expressed in a
temporal and tissue-specific manner during development
(Mullur et al. 2014), although, to date, differences in the
mechanisms of thyroid hormone action have not been
characterised in the pancreatic beta cell before and after
birth.
While fetal pancreatic beta cell proliferation rates and
total mass were influenced by thyroid hormone status, the
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Figure 3. Beta cell proliferation in insulin treated islets
A, immunofluorescent staining to show insulin (red), EdU (green) and DAPI (blue) in fetal ovine pancreatic islets
cultured in 10 ng ml−1 IGF-I (positive control) or 0, 0.1, 1.0 and 10 ng ml−1 insulin. Scale bar = 25 µm. B, mean
(±SEM) proliferation rates in beta cells after incubation with increasing doses of insulin compared to 10 ng ml−1
IGF-I. Values with different letters are significantly different from each other, one-way ANOVA, P < 0.05.
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maturity and functionalityof individual beta cells, in terms
of their capacity for insulin secretion, areunknown. In fetal
sheep, the prepartum surge in T3 may promote a switch in
pancreatic beta cell development from proliferation and
growth to maturation, in a manner similar to that seen
in cardiomyocytes near term (Chattergoon et al. 2012,
2014). Beta cells in the ovine fetal pancreas become more
responsive to glucose and amino acids with gestational
age, especially over the perinatal period when circulating
T3 concentrations rise ((Philipps et al. 1978, 1979; Fowden
& Hill, 2001). Treatment of immature postnatal rat
islets with T3 in vitro increases mRNA and protein
levels of musculoaponeurotic fibrosarcoma oncogene
family A (MAFA), a transcription factor essential for
beta cell maturation, and promotes glucose-stimulated
insulin secretion (Aguayo-Mazzucato et al. 2013). Similar
findings are observed in human fetal pancreatic islets
and embryonic stem cells differentiated towards beta
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Figure 4. Beta cell proliferation in leptin treated islets
A, immunofluorescent staining to show insulin (red), EdU (green) and DAPI (blue) in fetal ovine pancreatic islets
cultured in 10 ng ml−1 IGF-I (positive control) or 0, 0.1, 1.0 and 10 ng ml−1 leptin. Scale bar = 25 µm. B, mean
(±SEM) proliferation rates in beta cells after incubation with increasing doses of leptin compared to 10 ng ml−1
IGF-I. Values with different letters are significantly different from each other, one-way ANOVA, P < 0.05.
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cells where T3 induces the onset of glucose-sensitive
insulin synthesis and secretion (Aguayo-Mazzucato et al.
2015). Therefore, in fetal sheep, removal of the thyroid
gland and prevention of the normal rise in T3 near
term may maintain proliferation of pancreatic beta cells
and basal insulin secretion, and yet delay maturation
of glucose-stimulated insulin secretion. Future studies
will examine the expression of signalling molecules that
regulate beta cell maturation [pancreatic and duodenal
homeobox factor-1 (PDX1), neurogenin 3 (NGN3),
MAFA] and sensitivity to glucose (GLUT-2, glucokinase,
ATP-sensitive potassium and voltage-dependent calcium
ion channels) in fetal ovine pancreatic islets treated with
T3 in vitro and in those extracted from hypothyroid sheep
fetuses.
The effects of hypothyroidism on development of the
fetal endocrine pancreas may be mediated indirectly by
other hormones, such as insulin, leptin and IGFs. The
high circulating concentration of insulin seen in the
TX fetus may be part of a positive feedback loop, in
which hyperinsulinaemia promotes growth of the end-
ocrine pancreas and further insulin secretion. Indeed,
beta cell proliferation in vitro was stimulated by the
highest dose of insulin, which may reflect the local
concentration in the islets. In the pancreas of the hypo-
thyroid ovine fetus, therefore, the increase in insulin
secretion from the enlarged beta cell mass may drive
further beta cell proliferation in a paracrine manner.
Indeed, previous studies have shown that insulin activates
mammalian target of rapamycin (mTOR) and S6-kinase
via PI-3-kinase and mitogen-activated protein kinase
kinase (MEK1) pathways to stimulate pancreatic beta cell
proliferation in cell lines derived from fetal mice (Guillen
et al. 2006). No significant changes in IGF-I or II were
detected in the circulation of the hypothyroid ovine fetus.
IGF-I was a potent stimulus of beta cell proliferation
in vitro, although local IGF concentrations in the fetal
ovine pancreas were not determined and may have been
influenced by thyroid hormone deficiency.
The increased relative perirenal adipose mass observed
in the hypothyroid ovine fetus was likely to be res-
ponsible for the elevated circulating concentration of
leptin. In addition, there may be changes in leptin
synthesis and secretion from fetal adipocytes, possibly in
response to the rise in circulating insulin concentration
in utero. Indeed, thyroid hormone deficiency in fetal
sheep increases leptin mRNA abundance in perirenal
adipose tissue (O’Connor et al. 2007). Furthermore,
adipose leptin mRNA abundance and plasma leptin
concentration correlate with plasma insulin levels both
in sheep fetuses infused with insulin and in those hyper-
insulinaemic following maternal overnutrition (Devaskar
& Anthony, 2002; Mu¨hlha¨usler et al. 2007). Increased
plasma concentrations of leptin in the hypothyroid fetus
may contribute to the greater pancreatic beta cell mass as
the highest dose of leptin promoted beta cell proliferation
in vitro. Functional long-form leptin receptors have
been identified in pancreatic islets obtained from fetal
rats (Islam et al. 2000). Previous reports, however,
are conflicting about the role of leptin in determining
pancreatic beta cell mass, as it has been shown to have
both inhibitory and stimulatory effects, depending on
the experimental model used (Islam et al. 2000; Morioka
et al. 2007). In fetal rat islets and a rat-derived beta cell
line, leptin stimulates cell division (Islam et al. 1997,
2000), and islet size and beta cell number are reduced
in neonatal rats treated with a leptin antagonist (Attig
et al. 2011). In contrast, greater beta cell mass is observed
in mice with pancreas-specific deletion of the leptin
receptor, which appears to be due to beta cell hyper-
trophy rather than to any change in mitotic or apoptotic
markers (Morioka et al. 2007). The current study is the
first to report a dose-dependent, bimodal response in beta
cell proliferation to leptin in fetal ovine pancreatic islets
in vitro. The relationship between leptin and beta cell
proliferationmay arise from changes in the expression and
sensitivity of the leptin receptor to varying concentrations
of leptin. Several intracellular signalling pathways have
been shown to mediate the actions of leptin (Fru¨hbeck,
2006), which may be modulated differentially by the dose
of leptin in vitro. Taken together, the current findings
demonstrate thatT3, insulin and leptin all contribute to the
regulation of fetal beta cell mass in normal development
and during hypothyroidism.
The effects of hypothyroidism on development of
the fetal endocrine pancreas may have short- and
long-term consequences for growth and metabolism
in the offspring. Adult offspring of rats hypothyroid
during pregnancy show reduced glucose tolerance and
lower glucose-stimulated insulin secretion from isolated
pancreatic islets (Farahani et al. 2010; Karbalaei et al.
2014). Although these offspring were euthyroid in adult
life, the pancreatic islets were less sensitive to glucose with
lower insulin output per islet (Karbalaei et al. 2014). The
beta cell mass of these offspring was not determined at
birth or in adult life, and theremay be dynamic changes in
islet morphology and function over the perinatal period
and into adulthood.
In summary, this study shows that thyroid hormones
play a central role in controlling pancreatic beta cell mass
in the ovine fetus during late gestation. From studies both
in vivo and in vitro, the effects of hypothyroidism on
pancreatic beta cell proliferation and mass before birth
appear to be due not only to the deficit in circulating
thyroid hormones, but also to coincident changes in
insulin and leptin exposure. Whether prepartum changes
in thyroid hormones influence the functional maturity of
beta cells at birth with consequences for glucose-sensitive
insulin secretion and the development of diabetes in later
life remains to be determined.
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Translational perspective
Development of pancreatic beta cell mass and insulin secretion is essential for normal fetal growth
and carbohydratemetabolism before and after birth. Thyroid hormones are also important regulators
of growth and development in the fetus. Therefore, using the fetal sheep model, it was hypothesised
that growth retardation associated with thyroid hormone deficiency is due to reductions in pancreatic
beta cell mass and circulating insulin concentration in utero. Contrary to the original hypothesis,
greater beta cell proliferation and mass, and elevated plasma insulin concentration, were observed in
hypothyroid sheep fetuses. Hypothyroidism in utero also caused an increase in perirenal adipose tissue
mass and plasma leptin concentration. In isolated ovine fetal pancreatic islets, beta cell proliferation
wasdecreasedby thyroidhormone in adose-dependentmanner and stimulatedbyhigh concentrations
of insulin and leptin. Overall, these studies in vivo and in vitro show novel endocrine interactions in
the control of pancreatic beta cell mass before birth. Future studies will explore the functional capacity
of fetal beta cells exposed to varying concentrations of thyroid hormones, insulin and leptin, and will
characterise the molecular mechanisms underlying the endocrine control of beta cell proliferation
and maturation in utero. The finding that thyroid hormones influence beta cell development in
the fetus has important implications for growth and carbohydrate metabolism in infants affected by
congenital hypothyroidism andmaternal thyroid hormone disorders during pregnancy. In individuals
hypothyroid before birth, abnormalities in beta cell mass may predispose to pancreatic dysfunction
and type 2 diabetes in later life.
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